Tutorials
ValiRx PLC logo

ValiRx PLC

£ 0.13 (+0.78%) Aug 12
P/E:
At Loss
P/B:
2.34
Market Cap:
£ 11.59M ($ 14.07M)
Enterprise V:
£ 11.05M ($ 13.42M)
Volume:
1.82M
Avg Vol (2M):
1.50M
Also Trade In:
Volume:
1.82M
Market Cap £:
11.59M
Market Cap $:
14.07M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.50M
Enterprise Value £:
11.05M
Enterprise Value $:
13.42M
PB Ratio:
2.34
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

ValiRx PLC
NAICS : 325412
Chelmsford Road, Stonebridge House, Hatfield Heath, Essex, GBR, CM22 7BD
Description
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in the epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 10.24
Equity-to-Asset 1.02
Debt-to-Equity 0.02
Debt-to-EBITDA -0.04
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -3.3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 65.97
9-Day RSI 59.77
14-Day RSI 52.17
6-1 Month Momentum % -61.95
12-1 Month Momentum % -42.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.76
Quick Ratio 11.76
Cash Ratio 8.74

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -138.6

Profitability Rank

Name Current Vs Industry Vs History
ROE % -35.86
ROA % -36.1
ROIC % -52.74
ROC (Joel Greenblatt) % -2151.28
ROCE % -40.77

Financials (Next Earnings Date:2022-09-07 Est.)

LSE:VAL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 0
EPS (TTM) (£) -0.023
Beta 2.08
Volatility % 134.94
14-Day RSI 52.17
14-Day ATR (£) 0.011272
20-Day SMA (£) 0.114875
12-1 Month Momentum % -42.67
52-Week Range (£) 0.1 - 0.65
Shares Outstanding (Mil) 90.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ValiRx PLC Filings

Document Form Filing Date
No Filing Data